Ablation of TrkA function in the immune system causes B cell abnormalities

Area of Science:

• Immunology
• Neuroscience
• Developmental Biology

Background:

• The nerve growth factor (NGF) receptor TrkA is expressed in non-neural tissues, suggesting roles beyond the nervous system.
• Previous studies hypothesized NGF's importance in immune system development, but gene targeting was limited by early lethality.
• Conventional gene targeting approaches may not reflect physiological roles due to non-specific effects.

Purpose of the Study:

• To investigate the physiological role of TrkA in non-neuronal tissues, particularly within the immune system.
• To overcome the limitations of previous gene targeting strategies for studying TrkA function.
• To clarify the specific contributions of endogenous NGF to immune cell development and function.

Main Methods:

• Developed a novel 'reverse conditional' gene targeting strategy to restore TrkA function specifically in the nervous system.
• Generated mice lacking TrkA in non-neuronal tissues.
• Analyzed immune cell populations, serum immunoglobulin levels, and B1 cell accumulation in mutant mice.
• Utilized a classical reconstitution model with embryonic fetal liver from TrkA-null mice.

Main Results:

• Mice lacking TrkA in non-neuronal tissues were viable and appeared grossly normal with normal immune cell populations.
• Mutant mice exhibited elevated serum levels of certain immunoglobulin classes.
• Accumulation of B1 cells was observed in aging mutant mice.
• Reconstitution experiments confirmed endogenous NGF's modulation of B cell development via TrkA in vivo.

Conclusions:

• Endogenous nerve growth factor (NGF) modulates B cell development through its receptor TrkA in non-neuronal tissues.
• The 'reverse conditional' gene targeting strategy is effective for studying TrkA's non-neuronal functions.
• Pharmacological or immuno-depletion studies may not accurately reflect the physiological developmental roles of TrkA in the immune system.